Safety and Clinical Study of Calcium Pantetheine-S-Sulfonate in Patients with Hyperpigmentation

Ritsuko Hayakawa, Kayoko Matsunaga, Chikako Ukei, Kumiko Ohiwa

研究成果: Article査読

抄録

Calcium Pantetheine-S-Sulfonate (PaSSOsCa) is one of the pantothenic acid derivatives. We examined PaSSOaCa inhibition capacity of melanin formation in vitro. For the safety evaluation, we tested PaSSOsCa cream to the fifty one patients with skin diseases by closed patch method. And clinical evaluation of PaSSOsCa was performed in the fifty patients with hyperpigmentation by half side method. Results were as follows; 1. We showed PaSSOsCa inhibition capacity of melanin formation in vitro. 2. PaSSOsCa cream was shown to be safety to the human skin. 3. 10% PaSSOsCa cream lightened the skin hyperpigmentation more than placebo cream.

本文言語English
ページ(範囲)162-174
ページ数13
ジャーナルskin research
26
1
DOI
出版ステータスPublished - 01-01-1984
外部発表はい

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

フィンガープリント 「Safety and Clinical Study of Calcium Pantetheine-S-Sulfonate in Patients with Hyperpigmentation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル